Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
Dec 11, 2020 · The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to: prevent COVID-19 in individuals 12 years of age and older, and. provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated, authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated,...
Pfizer and BioNTech Announce Positive Topline Data for mRNA …
Oct 26, 2023 · Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula)*is FDA authorized under Emergency Use Authorization (EUA) to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 6 months through 11 years of age.
FDA Takes Action on Updated mRNA COVID-19 Vaccines to …
Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated...
FDA Approves First COVID-19 Vaccine
FDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19...
BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
Nov 4, 2024 · The COVID-19 vaccine maker reported a third-quarter net profit of 198.1 million euros, up from 160.6 million euros a year ago. BioNTech reported EPS of 81 cents, up from 66 a year ago.
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine …
Nov 16, 2022 · NEW YORK and MAINZ, GERMANY, NOVEMBER 16, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a Phase 1 study to evaluate the safety, tolerability and immunogenicity of a next generation COVID-19 vaccine candidate that aims to enhance SARS-CoV-2 T cell responses and potentially ...
Moderna, Pfizer say updated COVID shots generate strong …
Sept 6 (Reuters) - Moderna (MRNA.O) and rival Pfizer (PFE.N) on Wednesday said their updated COVID-19 vaccines generated strong responses in testing against the highly mutated BA.2.86...
US FDA authorizes Pfizer-BioNTech and Moderna's updated COVID …
Sept 11 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer (PFE.N) /BioNTech (22UAy.DE) and Moderna (MRNA.O) that target a...
The Updated COVID Vaccines Are Here: 9 Things to Know
Apr 19, 2024 · The Food and Drug Administration (FDA) authorized the updated vaccines by Pfizer-BioNTech and Moderna for infants and children ages 6 months to 11 years, and approved them for everyone ages 11 years and older. It also authorized an updated Novavax vaccine for those 12 and older in the fall of 2023.